Pharmacokinetics of VVN461 Ophthalmic Solution

NCT06906198 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: VVN461 Ophthalmic Solution 1.0%
DRUG: VVN461 Ophthalmic Solution 0.5%
DRUG: VVN461 Ophthalmic Solution 0.25%
DRUG: VVN461 Ophthalmic Solution Placebo

Sponsor

VivaVision Biotech, Inc